Company profile
Avivo Biomedical company profile
Avivo Biomedical operates as a preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type.
Business identity
- Website
- https://avivobio.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2020-01-01, Year
Headquarters
- Headquarters
- Sydney Forks, Nova Scotia, Canada
- Country code
- CA
- Continent
- North America